Paced Left Ventricular QRS Width and ECG Parameters Predict Outcomes After Cardiac Resynchronization Therapy
- 1 December 2011
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Arrhythmia and Electrophysiology
- Vol. 4 (6), 851-857
- https://doi.org/10.1161/circep.111.962605
Abstract
Background—: For patients with symptomatic New York Heart Association class III or IV, ejection fraction ≤35%, and QRS ≥130 ms, cardiac resynchronization therapy (CRT) has become an established treatment option. However, use of these implant criteria fails to result in clinical or echocardiographic improvement in 30% to 45% of CRT patients. Methods and Results—: The Predictors of Response to CRT (PROSPECT)-ECG is a substudy of the prospective observational PROSPECT trial. ECGs collected before, during, and after CRT implantation were analyzed. Primary outcomes were improvement in clinical composite score (CCS) and reduction of left ventricular end systolic volume (LVESV) of >15% after 6 months. Age, sex, cause of cardiomyopathy, myocardial infarction location, right ventricular function, mitral regurgitation, preimplantation QRS width, preimplantation PR interval, preimplantation right ventricular–paced QRS width, preimplantation axis categories, LV-paced QRS width, postimplantation axis categories, difference between biventricular (Bi-V) pacing and preimplantation QRS width, and QRS bundle branch morphological features were analyzed univariably in logistic regression models to predict outcomes. All significant predictors (α=0.1), age, and sex were used for multivariable analyses. Cardiomyopathy cause interaction and subanalyses were also performed. In multivariable analyses, only QRS left bundle branch morphological features predicted both CCS (odds ratio [OR]=2.46, P =0.02) and LVESV (OR=2.89, P =0.048) response. The difference between Bi-V and preimplantation QRS width predicted CCS improvement (OR=0.89, P =0.04). LV-paced QRS width predicted LVESV reduction (OR=0.86, P =0.01). Specifically, an LV-paced QRS width of ≤200 ms was predictive of nonischemic LVESV reduction (OR=5.12, P =0.01). Conclusions—: Baseline left bundle branch QRS morphological features, LV-paced QRS width, and the difference between Bi-V and preimplantation QRS width can predict positive outcomes after CRT and may represent a novel intraprocedural method to optimize coronary sinus lead placement. Clinical Trial Registration—: URL: http://www.clinicaltrials.gov . Unique identifier: NCT00253357.Keywords
This publication has 29 references indexed in Scilit:
- Cardiac Resynchronization Therapy in Non-Left Bundle Branch Block MorphologiesPacing and Clinical Electrophysiology, 2009
- Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysisEuropean Heart Journal, 2009
- Persistent Hemodynamic Benefits of Cardiac Resynchronization Therapy With Disease Progression in Advanced Heart FailureJournal of the American College of Cardiology, 2009
- The Impact of Myocardial Viability on the Clinical Outcome of Cardiac Resynchronization TherapyJournal of Cardiovascular Electrophysiology, 2008
- Prognostic Value of Electrocardiographic Measurements Before and After Cardiac Resynchronization Device Implantation in Patients With Heart Failure due to Ischemic or Nonischemic CardiomyopathyThe American Journal of Cardiology, 2008
- Cardiac-Resynchronization Therapy in Heart Failure with Narrow QRS ComplexesThe New England Journal of Medicine, 2007
- Effect of Total Scar Burden on Contrast-Enhanced Magnetic Resonance Imaging on Response to Cardiac Resynchronization TherapyThe American Journal of Cardiology, 2007
- Effect of Posterolateral Scar Tissue on Clinical and Echocardiographic Improvement After Cardiac Resynchronization TherapyCirculation, 2006
- Cardiac resynchronization therapy in patients with heart failure and conduction abnormalities other than left bundle‐branch block: Analysis of the multicenter insync randomized clinical evaluation (MIRACLE)Clinical Cardiology, 2004
- QRS Duration and Shortening to Predict Clinical Response to Cardiac Resynchronization Therapy in Patients with End‐Stage Heart FailurePacing and Clinical Electrophysiology, 2004